These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24113138)

  • 1. Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammation.
    Ramos MI; Tak PP; Lebre MC
    Autoimmun Rev; 2014 Feb; 13(2):117-24. PubMed ID: 24113138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells.
    Zhan Y; Vega-Ramos J; Carrington EM; Villadangos JA; Lew AM; Xu Y
    Eur J Immunol; 2012 Nov; 42(11):2889-900. PubMed ID: 22806691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells generated with Flt3L and exposed to apoptotic cells lack induction of T cell anergy and Foxp3⁺ regulatory T cell conversion in vitro.
    Pletinckx K; Lutz MB
    Immunobiology; 2014 Mar; 219(3):230-40. PubMed ID: 24252473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice.
    Walzer T; Brawand P; Swart D; Tocker J; De Smedt T
    J Allergy Clin Immunol; 2005 Jan; 115(1):192-9. PubMed ID: 15637568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
    Blyszczuk P; Behnke S; Lüscher TF; Eriksson U; Kania G
    Biochim Biophys Acta; 2013 Apr; 1833(4):934-44. PubMed ID: 23103516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo.
    Karsunky H; Merad M; Cozzio A; Weissman IL; Manz MG
    J Exp Med; 2003 Jul; 198(2):305-13. PubMed ID: 12874263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
    Lim SN; Kuhn S; Hyde E; Ronchese F
    J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF alters dendritic cells in autoimmune diseases.
    Li BZ; Ye QL; Xu WD; Li JH; Ye DQ; Xu Y
    Autoimmunity; 2013 Nov; 46(7):409-18. PubMed ID: 23786272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell homeostasis is maintained by nonhematopoietic and T-cell-produced Flt3-ligand in steady state and during immune responses.
    Saito Y; Boddupalli CS; Borsotti C; Manz MG
    Eur J Immunol; 2013 Jun; 43(6):1651-8. PubMed ID: 23519969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity.
    Tussiwand R; Onai N; Mazzucchelli L; Manz MG
    J Immunol; 2005 Sep; 175(6):3674-80. PubMed ID: 16148112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered compensatory cytokine signaling underlies the discrepancy between
    Durai V; Bagadia P; Briseño CG; Theisen DJ; Iwata A; Davidson JT; Gargaro M; Fremont DH; Murphy TL; Murphy KM
    J Exp Med; 2018 May; 215(5):1417-1435. PubMed ID: 29572360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.
    Whartenby KA; Calabresi PA; McCadden E; Nguyen B; Kardian D; Wang T; Mosse C; Pardoll DM; Small D
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16741-6. PubMed ID: 16272221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells.
    Lau-Kilby AW; Kretz CC; Pechhold S; Price JD; Dorta S; Ramos H; Trinchieri G; Tarbell KV
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2408-13. PubMed ID: 21262836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis.
    Svensson MN; Andersson SE; Erlandsson MC; Jonsson IM; Ekwall AK; Andersson KM; Nilsson A; Bian L; Brisslert M; Bokarewa MI
    PLoS One; 2013; 8(1):e54884. PubMed ID: 23349985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells and aging: consequences for autoimmunity.
    Agrawal A; Sridharan A; Prakash S; Agrawal H
    Expert Rev Clin Immunol; 2012 Jan; 8(1):73-80. PubMed ID: 22149342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instructive cytokine signals in dendritic cell lineage commitment.
    Schmid MA; Kingston D; Boddupalli S; Manz MG
    Immunol Rev; 2010 Mar; 234(1):32-44. PubMed ID: 20193010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection.
    Bohannon JK; Cui W; Toliver-Kinsky T
    BMC Immunol; 2009 Aug; 10():47. PubMed ID: 19715582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.